Short Interest in Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Grows By 165.4%

Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totaling 35,213 shares, a growth of 165.4% from the November 30th total of 13,267 shares. Based on an average daily volume of 38,130 shares, the days-to-cover ratio is currently 0.9 days. Approximately 5.4% of the company’s shares are short sold. Approximately 5.4% of the company’s shares are short sold. Based on an average daily volume of 38,130 shares, the days-to-cover ratio is currently 0.9 days.

Virtus LifeSci Biotech Clinical Trials ETF Stock Performance

Shares of Virtus LifeSci Biotech Clinical Trials ETF stock traded down $0.76 during trading hours on Friday, hitting $39.56. The company’s stock had a trading volume of 55,191 shares, compared to its average volume of 36,583. Virtus LifeSci Biotech Clinical Trials ETF has a twelve month low of $13.42 and a twelve month high of $40.82. The firm has a fifty day moving average of $35.18 and a 200-day moving average of $27.32.

Virtus LifeSci Biotech Clinical Trials ETF Company Profile

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.